Hormone therapy for osteoporosis uses estrogen, estrogen-like drugs, or other hormones to slow bone loss and lower fracture risk. Estrogen-based menopausal hormone therapy (MHT) prevents bone loss and reduces fractures in postmenopausal women, but because of its risks it is usually chosen for women under 60, or within about 10 years of menopause, who also have troublesome menopausal symptoms. Other hormone-based options include selective estrogen receptor modulators such as raloxifene, testosterone for men with proven low levels, and parathyroid hormone analogs that actively build bone.
Below I explain how each option works, who it suits, and how it fits alongside other osteoporosis treatments.
Why Hormones Matter for Bone
Bone is constantly being broken down by cells called osteoclasts and rebuilt by osteoblasts, a process called bone remodeling. Estrogen restrains osteoclasts. When estrogen falls sharply at menopause, breakdown outpaces rebuilding, and bone density drops most rapidly in the first several years afterward.
Men lose bone too, but more gradually, because testosterone declines slowly and some of it is converted to estrogen in the body. Other risk factors add to hormonal change, including older age, family history, low body weight, smoking, heavy alcohol use, long-term steroid medicines, and low calcium or vitamin D intake.
How Osteoporosis Is Diagnosed
Osteoporosis is often silent until a fracture occurs, though height loss, a stooped posture, or sudden back pain from a spinal fracture can be the first signs. An early diagnosis of osteoporosis relies on a DEXA scan (dual-energy X-ray absorptiometry), which measures bone mineral density and gives a T-score.
| T-score | Category |
|---|---|
| −1.0 and above | Normal bone density |
| Between −1.0 and −2.5 | Low bone mass (osteopenia) |
| −2.5 and below | Osteoporosis |
| −2.5 and below with a fragility fracture | Severe (established) osteoporosis |
Our page on osteoporosis levels explains these categories in more detail. Blood tests for calcium, vitamin D, kidney and thyroid function help exclude secondary causes before treatment is chosen.
Types of Hormone Therapy for Osteoporosis
| Therapy | How it works | Best suited to | Main cautions |
|---|---|---|---|
| Estrogen (MHT) | Slows bone breakdown | Recently menopausal women with symptoms | Blood clots, stroke, breast cancer with combined therapy |
| Raloxifene (SERM) | Acts like estrogen on bone, blocks it in breast | Postmenopausal women with spine fracture risk | Blood clots, hot flashes, leg cramps |
| Testosterone | Restores normal male hormone levels | Men with confirmed hypogonadism | Not a stand-alone osteoporosis treatment |
| PTH analogs (teriparatide, abaloparatide) | Stimulate new bone formation | Very high fracture risk | Daily injections, limited treatment duration |
Estrogen and Menopausal Hormone Therapy
Estrogen reduces fractures of the spine and hip in postmenopausal women. Women who still have a uterus need a progestogen added, because estrogen alone raises the risk of endometrial cancer. Women who have had a hysterectomy can take estrogen alone.
The risks depend on age, time since menopause, the type of hormone, and the route. They include blood clots, stroke, and a small increase in breast cancer risk with combined estrogen-progestogen therapy. Skin patches and gels carry a lower clot risk than tablets. The protective effect on bone fades after stopping, so a plan for what comes next is part of the decision.
Selective Estrogen Receptor Modulators
SERMs act like estrogen on bone but block estrogen in breast tissue. Raloxifene reduces spinal fractures, though it has not been shown to reduce hip fractures, and it lowers the risk of invasive breast cancer. It does not relieve hot flashes and may worsen them. Bazedoxifene combined with conjugated estrogens is another option for women with a uterus in some countries.
Testosterone in Men
Men with clearly low testosterone and symptoms may benefit from replacement, which can improve bone density. For men with osteoporosis, however, a proven osteoporosis drug is usually still needed alongside it.
Parathyroid Hormone Analogs
Teriparatide and abaloparatide are forms of parathyroid hormone given as daily injections. Unlike estrogen, they stimulate new bone formation. They are reserved for people at very high fracture risk and are followed by an anti-resorptive drug to keep the gains.
Where Hormone Therapy Fits in Overall Treatment
The broader treatment of osteoporosis often starts with non-hormonal medicines. Bisphosphonates such as alendronate and zoledronic acid, and the injection denosumab, are first-line choices for many older adults because their fracture benefits are well established and they avoid hormonal risks. Hormone therapy is most attractive when a younger postmenopausal woman needs both symptom relief and bone protection.
Lifestyle measures support every treatment:
- Weight-bearing and muscle-strengthening exercise, plus balance training to prevent falls.
- Adequate calcium, from diet where possible, and vitamin D.
- Stopping smoking and limiting alcohol.
- Making the home safer against falls.
Some people also ask about adjuncts such as low-intensity vibration plate therapy. These may complement exercise but do not replace proven medication.
Who Should Avoid Estrogen Therapy?
Estrogen is generally not advised for women with a history of breast or endometrial cancer, previous blood clots or stroke, active liver disease, unexplained vaginal bleeding, or established heart disease. Raloxifene is also avoided in women with a history of clots. Your doctor will weigh your personal and family history before recommending any hormone.
When to See a Doctor
Talk to your doctor if you have gone through menopause early, have lost height, have broken a bone from a minor fall, or have risk factors such as long-term steroid use. If you are already on hormone therapy, seek urgent care for calf swelling or pain, sudden breathlessness, chest pain, or stroke symptoms, and report any new breast lump or unexpected vaginal bleeding.
Frequently Asked Questions
Is hormone therapy a first-line treatment for osteoporosis?
Usually not for older women. It is mainly considered for women under 60 or within about 10 years of menopause who also have menopausal symptoms. Bisphosphonates or denosumab are more common first choices otherwise.
What happens to my bones when I stop estrogen?
Bone loss resumes after stopping, so the protective effect gradually disappears. Many women move on to another osteoporosis medicine to maintain bone density.
Can men take hormone therapy for osteoporosis?
Men with proven low testosterone may be offered replacement, and parathyroid hormone analogs can be used in men at very high risk. Estrogen and raloxifene are not used for male osteoporosis.
Are bioidentical hormones safer for bones?
Regulated body-identical estradiol and progesterone are standard options. Custom-compounded bioidentical products are not recommended, because their dose and purity are not consistently controlled.
Key Takeaways
- Estrogen therapy reduces fractures but is best suited to younger, recently menopausal women with symptoms.
- Raloxifene protects the spine and lowers breast cancer risk but not hip fracture risk.
- Parathyroid hormone analogs build bone for people at very high fracture risk.
- Every option works best alongside exercise, calcium, vitamin D, and fall prevention.
